Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yasutaka Sukawa

Showing results (1-10 of 59) with videos related to

Pageof 6
Sort By:
Gan to Kagaku Ryoho. Cancer & Chemotherapy|July 26, 2018
[Immune Checkpoint Induced Colitis]Yasutaka Sukawa, Yasuo Hamamoto, Takanori Kanai
Nihon Shokakibyo Gakkai Zasshi = the Japanese Journal of Gastro-Enterology|November 11, 2016
Association of colorectal carcinogenesis pathway with life style and intestinal microbiome based on the genome and epigenome abnormalitiesKatsuhiko Nosho, Yasutaka Sukawa, Hiroshi Nakase
Oncotargets and Therapy|December 13, 2018
Clinical efficacy of immune checkpoint inhibitors in the treatment of unresectable advanced or recurrent gastric cancer: an evidence-based review of therapiesKazuhiro Togasaki, Yasutaka Sukawa, Takanori Kanai, et al.
Japanese Journal of Clinical Oncology|January 25, 2026
Clinical outcome of 50 patients treated with eribulin for soft tissue sarcoma: a single-institute retrospective studyYudai Murayama, Rumi Nakagawa, Yasutaka Sukawa, et al.
Rare Tumors|June 5, 2026
Postoperative adjuvant eribulin in high-risk patients with soft tissue sarcoma: A retrospective study of eight casesYudai Murayama, Hirokazu Ideta, Rumi Nakagawa, et al.
Cancer Chemotherapy and Pharmacology|February 26, 2017
Positive relationship between subsequent chemotherapy and overall survival in pancreatic cancer: meta-analysis of postprogression survival for first-line chemotherapyAkiyoshi Kasuga, Yasuo Hamamoto, Ayano Takeuchi, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|January 21, 2010
[Pulmonary embolism during palliative chemotherapy including cetuximab for metastatic colorectal cancer]Akira Goto, Kazuya Suzuki, Yuka Hasegawa, et al.
Modern Rheumatology|February 6, 2007
Leukoencephalopathy during administration of etanercept for refractory rheumatoid arthritisMotohisa Yamamoto, Hiroki Takahashi, Hideki Wakasugi, et al.
BMJ Supportive & Palliative Care|October 15, 2021
Prospective feasibility study of indigo naturalis ointment for chemotherapy-induced oral mucositisKenro Hirata, Yuka Yamada, Yasuo Hamamoto, et al.
Oncology Letters|September 21, 2017
Benefit of rebiopsy for deciding treatment strategy in rectal cancer: A case reportKenta Kawasaki, Yasuo Hamamoto, Takeshi Suzuki, et al.
Pageof 6

Showing results (1-10 of 59) with videos related to

Sort By:
Pageof 6
Gan to Kagaku Ryoho. Cancer & Chemotherapy|July 26, 2018
[Immune Checkpoint Induced Colitis]Yasutaka Sukawa, Yasuo Hamamoto, Takanori Kanai
Nihon Shokakibyo Gakkai Zasshi = the Japanese Journal of Gastro-Enterology|November 11, 2016
Association of colorectal carcinogenesis pathway with life style and intestinal microbiome based on the genome and epigenome abnormalitiesKatsuhiko Nosho, Yasutaka Sukawa, Hiroshi Nakase
Oncotargets and Therapy|December 13, 2018
Clinical efficacy of immune checkpoint inhibitors in the treatment of unresectable advanced or recurrent gastric cancer: an evidence-based review of therapiesKazuhiro Togasaki, Yasutaka Sukawa, Takanori Kanai, et al.
Japanese Journal of Clinical Oncology|January 25, 2026
Clinical outcome of 50 patients treated with eribulin for soft tissue sarcoma: a single-institute retrospective studyYudai Murayama, Rumi Nakagawa, Yasutaka Sukawa, et al.
Rare Tumors|June 5, 2026
Postoperative adjuvant eribulin in high-risk patients with soft tissue sarcoma: A retrospective study of eight casesYudai Murayama, Hirokazu Ideta, Rumi Nakagawa, et al.
Cancer Chemotherapy and Pharmacology|February 26, 2017
Positive relationship between subsequent chemotherapy and overall survival in pancreatic cancer: meta-analysis of postprogression survival for first-line chemotherapyAkiyoshi Kasuga, Yasuo Hamamoto, Ayano Takeuchi, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|January 21, 2010
[Pulmonary embolism during palliative chemotherapy including cetuximab for metastatic colorectal cancer]Akira Goto, Kazuya Suzuki, Yuka Hasegawa, et al.
Modern Rheumatology|February 6, 2007
Leukoencephalopathy during administration of etanercept for refractory rheumatoid arthritisMotohisa Yamamoto, Hiroki Takahashi, Hideki Wakasugi, et al.
BMJ Supportive & Palliative Care|October 15, 2021
Prospective feasibility study of indigo naturalis ointment for chemotherapy-induced oral mucositisKenro Hirata, Yuka Yamada, Yasuo Hamamoto, et al.
Oncology Letters|September 21, 2017
Benefit of rebiopsy for deciding treatment strategy in rectal cancer: A case reportKenta Kawasaki, Yasuo Hamamoto, Takeshi Suzuki, et al.
Pageof 6